Neuralink receives FDA clearance to begin human trials of its brain-computer interface
in December, more than 1,500 animals had been killed in the development of the Neuralink BCI since 2018. The US Department of Agriculture's Inspector General hasThe FDA's reticence was also born from concerns about the design and function of the interface when implanted in humans.
"The agency’s major safety concerns involved the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue," current and former Neuralink employees toldGreat deals on consumer electronics delivered straight to your inbox, curated by Engadget’s editorial team.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Elon Musk’s Neuralink gets FDA approval for human test of brain implantsNeuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Read more »
Elon Musk’s Neuralink Cleared By FDA for In-Human StudiesDespite a rocky past with federal officials and an initial rejection in March from the FDA, Elon Musk’s brain-chip company Neuralink shared on Twitter that it has received FDA approval to launch its first in-human clinical study.
Read more »
Elon Musk's Neuralink gets FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.
Read more »
The FDA will apparently let Elon Musk put a computer in a human’s brainRecruitment for Neuralink’s trial isn’t open yet.
Read more »
FDA Approves Buprenorphine Injection for Opioid Use DisorderThe FDA has approved extended-release injection buprenorphine (Brixadi, Braeburn Inc) for the treatment of moderate to severe opioid use disorder.
Read more »
TransCon PTH Nears US Approval for Hypoparathyroidism?Palopegteriparatide is a potential long-term therapy for adults with hypoparathyroidism, new findings suggest.
Read more »